Statistik Asas
| CIK | 1524190 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to iKang Healthcare Group, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| February 15, 2019 |
KANG / iKang Healthcare Group, Inc. / GIC Private Ltd - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* iKang Healthcare Group, Inc. (Name of Issuer) Class A common shares, par value US$0.01 per share, including in the form of American Depositary Shares (each representing 1/2 of a Class A common share) (Title of Class of Securities) 45174L108 (CUSIP Number |
|
| February 14, 2019 |
KANG / iKang Healthcare Group, Inc. / GIC Private Ltd - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* iKang Healthcare Group, Inc. (Name of Issuer) Class A common shares, par value US$0.01 per share, including in the form of American Depositary Shares (each representing 1/2 of a Class A common share) (Title of Class of Securities) 45174L108 (CUSIP Number |
|
| January 31, 2019 |
KANG / iKang Healthcare Group, Inc. 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specifie |
|
| January 24, 2019 |
EX-7.31 3 a19-32531ex7d31.htm EX-7.31 Exhibit 7.31 SHARE PURCHASE AGREEMENT This SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 8, 2019 by and between Gold Partner Consultants Limited, company incorporated under the laws of the British Virgin Islands (the “Seller”) and Time Partners L.P., an exempted limited partnership registered under the laws of the Cayman Is |
|
| January 24, 2019 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment SC 13D/A 1 a19-32531sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 12)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6 |
|
| January 24, 2019 |
EX-7.32 4 a19-32531ex7d32.htm EX-7.32 Exhibit 7.32 This Deed of Release is made the 18th of January 2019 By: (1) GOPHER GLOBAL CREDIT FUND II (the “Mortgagee”). In Favour of: (2) SHANGHAIMED, INC. of a company incorporated and existing under the laws of the British Virgin Islands (registration number: 572820) with its registered office at Moore Stephens International Services (BVI) Limited, Palm G |
|
| January 24, 2019 |
Exhibit 7.33 质押解除通知书 Notice of Release of Pledge 致：iKang Healthcare Group, Inc.（开曼群岛） TO：iKang Healthcare Group, Inc. (Cayman Islands) 我公司，中航信托股份有限公司，特此确认，根据ShanghaiMed, Inc.与我公司于2017年11月19日签署的《股份质押合同》（编号AVICTC2017X1276-4）的有关规定，双方在质押股份（定义参见贵司于2017年11月15日出具的《声明确认函》）上设定的质押或者其他权利负担已全部解除。 Our company, AVIC Trust Co., Ltd., hereby confirms that in accordance with Share Pledge Contract (CONTRACT NO. AVI |
|
| January 24, 2019 |
EX-7.30 2 a19-32531ex7d30.htm EX-7.30 Exhibit 7.30 AGREEMENT OF JOINT FILING In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendment |
|
| January 23, 2019 |
KANG / iKang Healthcare Group, Inc. / Top Fortune Win Ltd. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 4) iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, |
|
| January 18, 2019 |
KANG / iKang Healthcare Group, Inc. S-8 POS As filed with the Securities and Exchange Commission on January 18, 2019 Registration No. |
|
| January 18, 2019 |
KANG / iKang Healthcare Group, Inc. S-8 POS S-8 POS 1 a18-1423011s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 18, 2019 Registration No. 333-197289 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 POST-EFFECTIVE AMENDMENT NO. 1 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) Cayman Isl |
|
| January 18, 2019 |
iKang Announces Completion of Going Private Transaction Exhibit 99.1 iKang Announces Completion of Going Private Transaction BEIJING, January 18, 2019 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced the completion of its merger (the “Merger”) with IK Healthcare Merger Limited (“Merger Sub”), a wholly owned subsidiary of IK H |
|
| January 18, 2019 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2019 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing |
|
| January 18, 2019 |
KANG / iKang Healthcare Group, Inc. / Ikang Healthcare Group, Inc. - SC 13E3/A SC 13E3/A 1 a2237359zsc13e3a.htm SC 13E3/A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 AMENDMENT NO. 5 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Name of the Issuer) iKang Healthcare Group, Inc. |
|
| December 21, 2018 |
iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 Exhibit 99.1 iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced its unaudited financial results for the fiscal second quarter ende |
|
| December 21, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) 6-K 1 a18-4193416k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Roa |
|
| December 18, 2018 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 11)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyan |
|
| December 18, 2018 |
KANG / iKang Healthcare Group, Inc. / Top Fortune Win Ltd. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 3) iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, |
|
| December 14, 2018 |
iKang Enters into Amendment No. 3 to Merger Agreement for Going Private Transaction EX-99.2 3 a18-142309ex99d2.htm EX-99.2 Exhibit 99.2 iKang Enters into Amendment No. 3 to Merger Agreement for Going Private Transaction BEIJING, December 14, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that it has entered into an amendment No. 3 (“Amendment No. |
|
| December 14, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) 6-K 1 a18-1423096k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Roa |
|
| December 14, 2018 |
AMENDMENT NO. 3 TO THE AGREEMENT AND PLAN OF MERGER Exhibit 99.1 Execution Version AMENDMENT NO. 3 TO THE AGREEMENT AND PLAN OF MERGER AMENDMENT NO. 3 TO THE AGREEMENT AND PLAN OF MERGER, dated as of December 14, 2018 (this “Amendment”), is entered by and among IK Healthcare Investment Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“Parent”), IK Healthcare Merger Limited, an exempted company w |
|
| December 14, 2018 |
KANG / iKang Healthcare Group, Inc. / Ikang Healthcare Group, Inc. - SC 13E3/A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 29, 2018 |
iKang Healthcare Group, Inc. Extends Shareholder Rights Plan EX-99.1 3 a18-408121ex99d1.htm EX-99.1 Exhibit 99.1 iKang Healthcare Group, Inc. Extends Shareholder Rights Plan BEIJING, November 29, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), announced today that its board of directors (the “Board of Directors”) has unanimously approved the extension of its Rights Agreement, presently scheduled to expire on D |
|
| November 29, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2018. Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beiji |
|
| November 29, 2018 |
AMENDMENT NO. 5 TO RIGHTS AGREEMENT EX-4.1 2 a18-408121ex4d1.htm EX-4.1 Exhibit 4.1 AMENDMENT NO. 5 TO RIGHTS AGREEMENT AMENDMENT NO. 5 (this “Amendment”), dated as of November 29, 2018, to the Rights Agreement (the “Rights Agreement”), dated as of December 2, 2015 (as amended by Amendment No. 1 thereto dated as of November 28, 2016, Amendment No. 2 thereto dated as of November 29, 2017, Amendment No. 3 thereto dated as of March 26, |
|
| November 29, 2018 |
KANG / iKang Healthcare Group, Inc. 8-A12B/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A Amendment No. 5 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State of incorporation or organization) (IRS Employer Identification No.) B-6F |
|
| November 1, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijin |
|
| November 1, 2018 |
iKang Announces Update on Going Private Transaction Exhibit 99.1 iKang Announces Update on Going Private Transaction BEIJING, November 1, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today made the following announcement regarding the proposed merger (the “Merger”) pursuant to the agreement and plan of merger dated as of March 2 |
|
| September 28, 2018 |
iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2018 Exhibit 99.1 iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2018 BEIJING, SEPTEMBER 27, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced its unaudited financial results for the fiscal first quarter ended June |
|
| September 28, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) 6-K 1 a18-3609916k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Ro |
|
| September 27, 2018 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 10)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyan |
|
| September 27, 2018 |
KANG / iKang Healthcare Group, Inc. / Top Fortune Win Ltd. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 * (Amendment No. 2) iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, |
|
| September 26, 2018 |
KANG / iKang Healthcare Group, Inc. / Ikang Healthcare Group, Inc. - SC 13E3/A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 25, 2018 |
AMENDMENT NO. 2 TO THE AGREEMENT AND PLAN OF MERGER Exhibit 99.1 Execution Version AMENDMENT NO. 2 TO THE AGREEMENT AND PLAN OF MERGER AMENDMENT NO. 2 TO THE AGREEMENT AND PLAN OF MERGER, dated as of September 25, 2018 (this “Amendment”), is entered by and among IK Healthcare Investment Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“Parent”), IK Healthcare Merger Limited, an exempted company |
|
| September 25, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beiji |
|
| September 25, 2018 |
iKang Enters into Amendment No. 2 to Merger Agreement for Going Private Transaction Exhibit 99.2 iKang Enters into Amendment No. 2 to Merger Agreement for Going Private Transaction BEIJING, September 25, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that it has entered into an amendment No. 2 (“Amendment No. 2”) to amend its previously announced |
|
| September 7, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beiji |
|
| September 7, 2018 |
iKang Announces Buyer Group’s Re-Evaluation of Merger and Request for Extension of Termination Date EX-99.1 2 a18-271321ex99d1.htm EX-99.1 Exhibit 99.1 iKang Announces Buyer Group’s Re-Evaluation of Merger and Request for Extension of Termination Date BEIJING, September 7, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that IK Healthcare Investment Limited (“Par |
|
| September 4, 2018 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment SC 13D/A 1 a18-241271sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 9)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6 |
|
| September 4, 2018 |
Exhibit 7.27 Execution Version Equitable Mortgage Over Shares in iKang Healthcare Group, Inc. 24 August 2018 SHANGHAIMED, INC. (as Mortgagor) and GOPHER GLOBAL CREDIT FUND II (as Mortgagee) This Equitable Mortgage is made on 24 day of August 2018 Between: (1) SHANGHAIMED, INC., a company incorporated and existing under the laws of the British Virgin Islands (registration number: 572820) with its r |
|
| August 20, 2018 |
iKang Announces Shareholders’ Approval of “Going Private” Transaction Exhibit 99.1 iKang Announces Shareholders’ Approval of “Going Private” Transaction BEIJING, August 20, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that, at an extraordinary general meeting (the “EGM”) held today, the Company’s shareholders voted in favor of the |
|
| August 20, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing |
|
| August 14, 2018 |
iKang Announces Further Update on “Going Private” Transaction Exhibit 99.1 iKang Announces Further Update on “Going Private” Transaction BEIJING, August 15, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that, as of the close of business (New York time) on August 14, 2018, it has received notices of objection under Section 2 |
|
| August 14, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing |
|
| August 10, 2018 |
Exhibit 4.53 Agreement Extension Notice To: iKang Health Technology Group Co., Ltd., Mr. Boquan He and Mr. Lee Ligang Zhang Date of Notification: March 22, 2018 Whereas iKang Health Technology Group Co., Ltd. (formerly known as Shanghai Guobin Medical Holding Co., Ltd., hereinafter referred to as “iKang Technology”), Mr. Boquan He, Mr. Lee Ligang Zhang and iKang Healthcare Technology (Beijing) Co. |
|
| August 10, 2018 |
EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of iKang Healthcare Group, Inc. (the “Company”) on Form 20-F for the year ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yang Chen, Chief Financial Officer of the Company, certif |
|
| August 10, 2018 |
EX-4.51 6 a18-172151ex4d51.htm EX-4.51 Exhibit 4.51 Forward Share Purchase Agreement Forward Share Purchase Agreement Contract No.: AVICTC2017X0652-3 Seller: Hangkang Investment Management Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area Buyer: iKang Guobin Medical Examination Management Co., Ltd. Forward Share Purchase Agreement Seller: Hangkang Investment Management Partnersh |
|
| August 10, 2018 |
Exhibit 4.50 (Limited Partnership) Agreement of Hangkang Investment Management Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area AVICTC2017X0652-1 December 2017 Table of Contents Article 1 Establishment of Limited Partnership 5 1.1 Establishment Basis 5 1.2 Name of Limited Partnership 5 1.3 Main Business Premises 5 1.4 Partnership Purpose and Business Scope 6 1.5 Partners 6 1.6 |
|
| August 10, 2018 |
EX-4.47 2 a18-172151ex4d47.htm EX-4.47 Exhibit 4.47 Strictly Confidential Supplemental Agreement II to the Loan Agreement This Supplemental Agreement II to the Loan Agreement (hereinafter referred to as the “Supplemental Agreement II”) is entered into by the following Parties in accordance with relevant Chinese laws, regulations and rules on July 10, 2017 in the People’s Republic of China (hereina |
|
| August 10, 2018 |
KANG / iKang Healthcare Group, Inc. 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 or x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2018. or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| August 10, 2018 |
EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of iKang Healthcare Group, Inc. (the “Company”) on Form 20-F for the year ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lee Ligang Zhang, Chief Executive Officer of the Company, |
|
| August 10, 2018 |
EX-15.3 17 a18-172151ex15d3.htm EX-15.3 Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and 333-202544 on Form S-8 of our reports dated August 10, 2018, relating to the consolidated financial statements of iKang Healthcare Group, Inc.(“the Company”), its subsidiaries, its variable inter |
|
| August 10, 2018 |
Exhibit 4.54 Supplemental Agreement III to the Loan Agreement This Supplemental Agreement III to the Loan Agreement (hereinafter referred to as the “Agreement”) is entered into by the following Parties on March 23, 2018 in Beijing, China: Party A: iKang Health Technology Group Co., Ltd. (hereinafter referred to as the “Borrower”) Registered address: Room 3E-2398, 3/F, No. 2123 Pudong Avenue, China |
|
| August 10, 2018 |
EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st |
|
| August 10, 2018 |
Exhibit 4.48 No.: [XYZG[2017]-H20170009-HHXY] |
|
| August 10, 2018 |
EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Lee Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make |
|
| August 10, 2018 |
Consent of Conyers Dill & Pearman Exhibit 15.1 10 August, 2018 Matter No.:827098 Doc Ref: 104361926 The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) We refer to the annual report of the Company for the fiscal year ended 31 March, 2018 on Form 20-F filed pursuant to Section 13 or 15(D) |
|
| August 10, 2018 |
Consent of King & Wood Mallesons Exhibit 15.2 August 10, 2018 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Attention: The Board of Directors Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) We, King & Wood Mallesons, consent to the reference to our firm under the captions of “Item 3.D — Risk Factors” and “Item 4.C — Organizational Structure |
|
| August 10, 2018 |
Exhibit 4.49 Strictly Confidential Supplemental Agreement to the Investment Agreement This Supplemental Agreement to the Investment Agreement (the “Supplemental Agreement”) was entered into by the following parties in accordance with relevant Chinese laws, regulations and rules on December 13, 2017: Investor: Zhongjin Qizhi (Shanghai) Equity Investment Center (Limited Partnership) Investee: iKang |
|
| August 10, 2018 |
EX-4.52 7 a18-172151ex4d52.htm EX-4.52 Exhibit 4.52 Letter of Authorization for Management Rights Principal: Hangkang Investment Management Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area Uniform Social Credit Code: 91330206MA2AF7HM97 Agent: iKang Guobin Medical Examination Management Co., Ltd. Uniform Social Credit Code: 911100007667680727 Whereas, 1. The Principal holds 25% |
|
| July 30, 2018 |
KANG / iKang Healthcare Group, Inc. NT 20-F OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response . . . . . . 2.50 SEC FILE NUMBER 001-36403 CUSIP NUMBER 45174L108 (Check one): o Form 10-K x Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: |
|
| July 16, 2018 |
iKang Announces Extraordinary General Meeting of Shareholders Exhibit 99.1 iKang Announces Extraordinary General Meeting of Shareholders BEIJING, July 16, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that it has called an extraordinary general meeting of shareholders (the “EGM”) to be held on August 20, 2018 at 10 a.m. (Be |
|
| July 16, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) 6-K 1 a18-1725816k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Ch |
|
| July 16, 2018 |
PROXY STATEMENT OF THE COMPANY EX-99.(A)-(1) 2 a2236125zex-99a1.htm EX-99.(A)-(1) Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents Exhibit (a)-(1) PROXY STATEMENT OF THE COMPANY July 16, 2018 Shareholders of iKang Healthcare Group, Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general mee |
|
| July 16, 2018 |
KANG / iKang Healthcare Group, Inc. / Ikang Healthcare Group, Inc. - SC 13E3/A SC 13E3/A 1 a2236125zsc13e3a.htm SC 13E3/A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 AMENDMENT NO. 2 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Name of the Issuer) iKang Healthcare Group, Inc. |
|
| June 22, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 10 |
|
| June 22, 2018 |
Exhibit 99.1 iKang Announces Unaudited Financial Results for the Fiscal Fourth Quarter and the Fiscal Year 2017 Ended March 31, 2018 BEIJING, JUNE 21, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced its unaudited financial results for the fiscal fo |
|
| June 22, 2018 |
KANG / iKang Healthcare Group, Inc. SIMPSON THACHER & BARTLETT ICBC TOWER, 35TH FLOOR 3 GARDEN ROAD, CENTRAL HONG KONG TELEPHONE: +852-2514-7600 FACSIMILE: +852-2869-7694 DIRECT DIAL NUMBER E-MAIL ADDRESS +852-2514-7622 ksudol@stblaw. |
|
| June 22, 2018 |
KANG / iKang Healthcare Group, Inc. / Ikang Healthcare Group, Inc. - SC 13E3/A SC 13E3/A 1 a2236065zsc13e3a.htm SC 13E3/A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 AMENDMENT NO. 1 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Name of the Issuer) iKang Healthcare Group, Inc. |
|
| June 22, 2018 |
PROXY STATEMENT OF THE COMPANY EX-99.(A)-(1) 2 a2236065zex-99a1.htm EX-99.(A)-(1) Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents Exhibit (a)-(1) PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of |
|
| June 4, 2018 |
KANG / iKang Healthcare Group, Inc. / Top Fortune Win Ltd. - SC 13D/A Activist Investment SC 13D/A 1 a18-147351sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 1) iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** |
|
| June 4, 2018 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 8)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang |
|
| May 30, 2018 |
AMENDED AND RESTATED LIMITED GUARANTEE EX-99.(D)-(8) 11 a2235841zex-99d8.htm EX-99.(D)-(8) Exhibit (d)-(8) Execution Version AMENDED AND RESTATED LIMITED GUARANTEE AMENDED AND RESTATED LIMITED GUARANTEE, dated as of May 29, 2018 (this “Limited Guarantee”), by Taobao China Holding Limited (the “Guarantor”) in favor of iKang Healthcare Group, Inc., an exempted company with limited liability incorporated under the Laws of the Cayman Islan |
|
| May 30, 2018 |
AMENDED AND RESTATED LIMITED GUARANTEE Exhibit (d)-(5) Execution Version AMENDED AND RESTATED LIMITED GUARANTEE AMENDED AND RESTATED LIMITED GUARANTEE, dated as of May 29, 2018 (this “Limited Guarantee”), by ShanghaiMed, Inc. |
|
| May 30, 2018 |
AMENDED AND RESTATED LIMITED GUARANTEE Exhibit (d)-(7) Execution Version AMENDED AND RESTATED LIMITED GUARANTEE AMENDED AND RESTATED LIMITED GUARANTEE, dated as of May 29, 2018 (this “Limited Guarantee”), by Yunfeng Fund III Parallel Fund, L. |
|
| May 30, 2018 |
AMENDED AND RESTATED LIMITED GUARANTEE EX-99.(D)-(6) 9 a2235841zex-99d6.htm EX-99.(D)(6) Exhibit (d)-(6) Execution Version AMENDED AND RESTATED LIMITED GUARANTEE AMENDED AND RESTATED LIMITED GUARANTEE, dated as of May 29, 2018 (this “Limited Guarantee”), by Yunfeng Fund III, L.P. (the “Guarantor”) in favor of iKang Healthcare Group, Inc., an exempted company with limited liability incorporated under the Laws of the Cayman Islands (the |
|
| May 30, 2018 |
EX-99.(A)-(1) 2 a2235841zex-99a1.htm EX-99.(A)-(1) Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents Exhibit (a)-(1) PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of |
|
| May 30, 2018 |
KANG / iKang Healthcare Group, Inc. / Ikang Healthcare Group, Inc. - SC 13E3 SC 13E3 1 a2235841zsc13e3.htm SC 13E3 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Name of the Issuer) iKang Healthcare Group, Inc. IK Healthcare Holding |
|
| May 30, 2018 |
EX-99.(D)-(10) 13 a2235841zex-99d10.htm EX-99.(D)-(10) Exhibit (d)-(10) Execution Version LIMITED GUARANTEE LIMITED GUARANTEE, dated as of May 29, 2018 (this “Limited Guarantee”), by Boyu Capital Fund III, L.P. (the “Guarantor”) in favor of iKang Healthcare Group, Inc., an exempted company with limited liability incorporated under the Laws of the Cayman Islands (the “Guaranteed Party”). WHEREAS, p |
|
| May 30, 2018 |
AMENDED AND RESTATED EQUITY COMMITMENT LETTER May 29, 2018 EX-99.(B)-(3) 5 a2235841zex-99b3.htm EX-99.(B)-(3) Exhibit (b)-(3) Execution Version AMENDED AND RESTATED EQUITY COMMITMENT LETTER May 29, 2018 IK Healthcare Investment Limited Suite 3501, K.Wah Centre 1010 Huaihai Road (M) Shanghai, 200031 China Ladies and Gentlemen: This letter agreement amends and restates the letter agreement, dated March 26, 2018 (the “Prior Equity Commitment Letter”), from T |
|
| May 30, 2018 |
EQUITY COMMITMENT LETTER May 29, 2018 Exhibit (b)-(4) Execution Version EQUITY COMMITMENT LETTER May 29, 2018 IK Healthcare Investment Limited Suite 3501, K. |
|
| May 30, 2018 |
AMENDED AND RESTATED LIMITED GUARANTEE EX-99.(D)-(9) 12 a2235841zex-99d9.htm EX-99.(D)-(9) Exhibit (d)-(9) Execution Version AMENDED AND RESTATED LIMITED GUARANTEE AMENDED AND RESTATED LIMITED GUARANTEE, dated as of May 29, 2018 (this “Limited Guarantee”), by Top Fortune Win Ltd. (the “Guarantor”) in favor of iKang Healthcare Group, Inc., an exempted company with limited liability incorporated under the Laws of the Cayman Islands (the |
|
| May 30, 2018 |
AMENDED AND RESTATED INTERIM INVESTORS AGREEMENT Exhibit (d)-(11) Execution Version AMENDED AND RESTATED INTERIM INVESTORS AGREEMENT This Amended and Restated Interim Investors Agreement (this “Agreement”) is made as of May 29, 2018 by and among Yunfeng Fund III, L. |
|
| May 30, 2018 |
S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L DISCUSSION MATERIALS March 26, 2018 S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L DISCUSSION MATERIALS March 26, 2018 This presentation was prepared exclusively for the benefit and internal use of the Special Committee of the Board of Directors (the “Special Committee”) of iKang Healthcare Group, Inc. |
|
| May 30, 2018 |
AMENDED AND RESTATED EQUITY COMMITMENT LETTER May 29, 2018 Exhibit (b)-(2) Execution Version AMENDED AND RESTATED EQUITY COMMITMENT LETTER May 29, 2018 IK Healthcare Investment Limited Suite 3501, K. |
|
| May 30, 2018 |
AMENDED AND RESTATED EQUITY COMMITMENT LETTER May 29, 2018 Exhibit (b)-(1) Execution Version AMENDED AND RESTATED EQUITY COMMITMENT LETTER May 29, 2018 IK Healthcare Investment Limited Suite 3501, K. |
|
| May 29, 2018 |
KANG / iKang Healthcare Group, Inc. 8-A12B/A 8-A12B/A 1 a18-1423068a12ba.htm 8-A12B/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A Amendment No. 4 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State of incorporation or organizatio |
|
| May 29, 2018 |
AMENDMENT NO. 4 TO RIGHTS AGREEMENT EX-4.1 2 a18-142305ex4d1.htm EX-4.1 Exhibit 4.1 Execution Version AMENDMENT NO. 4 TO RIGHTS AGREEMENT AMENDMENT NO. 4 (this “Amendment”), dated as of May 29, 2018, to the Rights Agreement (the “Rights Agreement”) dated as of December 2, 2015 (as amended by Amendment No. 1 thereto dated as of November 28, 2016, Amendment No. 2 thereto dated as of November 29, 2017 and Amendment No. 3 thereto dated |
|
| May 29, 2018 |
iKang Enters into Amendment to Merger Agreement for Going Private Transaction Exhibit 99.2 iKang Enters into Amendment to Merger Agreement for Going Private Transaction BEIJING, May 29, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that it has entered into an amendment (the “Amendment”) to its previously announced Agreement and Plan of Mer |
|
| May 29, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100 |
|
| May 29, 2018 |
AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER Exhibit 99.1 Execution Version AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER, dated as of May 29, 2018 (this “Amendment”), is entered by and among IK Healthcare Investment Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“Parent”), IK Healthcare Merger Limited, an exempted company with l |
|
| April 24, 2018 |
Exhibit 7.18 This Deed of Partial Release is made the 6th day of April 2018 Between: (1) GOPHER GLOBAL CREDIT FUND II (the “Mortgagee”); and SHANGHAIMED, INC., a company incorporated and existing under the laws of the British Virgin Islands (registration number: 572820) with its registered office at Moore Stephens International Services (BVI) Limited, Palm Grove House, P.O. Box 3186, Wickhams Cay |
|
| April 24, 2018 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment SC 13D/A 1 a18-120161sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 7)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6 |
|
| April 5, 2018 |
Exhibit 99.3 Execution Version SUPPORT AGREEMENT This SUPPORT AGREEMENT (this “Agreement”) is entered into as of March 26, 2018 by and among (1) IK Healthcare Holdings Limited, a Cayman Islands exempted company (“Holdco”), (2) IK Healthcare Investment Limited, a Cayman Islands exempted company and a wholly-owned subsidiary of Holdco (“Parent”), (3) those shareholders of iKang Healthcare Group, Inc |
|
| April 5, 2018 |
KANG / iKang Healthcare Group, Inc. / Top Fortune Win Ltd. - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 18 |
|
| April 5, 2018 |
EX-99.5 5 a18-95831ex99d5.htm EX-99.5 Exhibit 99.5 EXECUTION VERSION INTERIM INVESTORS AGREEMENT This Interim Investors Agreement (this “Agreement”) is made as of March 26, 2018 by and among Yunfeng Fund III, L.P. and Yunfeng Fund III Parallel Fund, L.P. (collectively “YFC”), each an exempted limited partnership established under the laws of the Cayman Islands, Taobao China Holding Limited, a comp |
|
| April 5, 2018 |
Exhibit 99.1 Joint Filing Agreement The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accurac |
|
| April 5, 2018 |
Exhibit 99.4 EXECUTION VERSION LIMITED GUARANTEE LIMITED GUARANTEE, dated as of March 26, 2018 (this “Limited Guarantee”), by Top Fortune Win Ltd. (the “Guarantor”) in favor of iKang Healthcare Group, Inc., an exempted company with limited liability incorporated under the Laws of the Cayman Islands (the “Guaranteed Party”). 1. GUARANTEE. (a) To induce the Guaranteed Party to enter into that certai |
|
| March 28, 2018 |
KANG / iKang Healthcare Group, Inc. 8-A12B/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A Amendment No. 3 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State of incorporation or organization) (IRS Employer Identification No.) B-6F |
|
| March 28, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) 6-K 1 a18-912716k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Ch |
|
| March 28, 2018 |
Exhibit 99.1 Execution Version AGREEMENT AND PLAN OF MERGER among IK HEALTHCARE INVESTMENT LIMITED, IK HEALTHCARE MERGER LIMITED and IKANG HEALTHCARE GROUP, INC. Dated as of March 26, 2018 TABLE OF CONTENTS Page ARTICLE I THE MERGER Section 1.01 The Merger 7 Section 1.02 Closing; Closing Date 7 Section 1.03 Effective Time 7 Section 1.04 Effects of the Merger 7 Section 1.05 Memorandum and Articles |
|
| March 28, 2018 |
AMENDMENT NO. 3 TO RIGHTS AGREEMENT Exhibit 4.1 EXECUTION VERSION AMENDMENT NO. 3 TO RIGHTS AGREEMENT AMENDMENT NO. 3 (this “Amendment”), dated as of March 26, 2018, to the Rights Agreement (the “Rights Agreement”) dated as of December 2, 2015 (as amended by Amendment No. 1 thereto dated as of November 28, 2016 and Amendment No. 2 thereto dated as of November 29, 2017), by and between iKang Healthcare Group, Inc., a company incorpor |
|
| March 28, 2018 |
EX-7.12 2 a18-91441ex7d12.htm EX-7.12 Exhibit 7.12 General Pledge and Assignment Agreement (Pledgor and Borrower are identical} ShanghaiMed, Inc. Name(s), first name(s) / Company name of the Pledgor(s) Moore Stephens International, Services (BVI) Limited, Palm Grove House, Wickhams Cay I, Tortola, Post Office Box 3186, Road Town, Virgin Islands, British Address(es) of the Pledgor(s) (hereinafter “ |
|
| March 28, 2018 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 5)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang |
|
| March 28, 2018 |
Exhibit 7.15 Execution Version SUPPORT AGREEMENT This SUPPORT AGREEMENT (this “Agreement”) is entered into as of March 26, 2018 by and among (1) IK Healthcare Holdings Limited, a Cayman Islands exempted company (“Holdco”), (2) IK Healthcare Investment Limited, a Cayman Islands exempted company and a wholly-owned subsidiary of Holdco (“Parent”), (3) those shareholders of iKang Healthcare Group, Inc |
|
| March 28, 2018 |
EX-7.16 3 a18-92431ex7d16.htm EX-7.16 Exhibit 7.16 EXECUTION VERSION LIMITED GUARANTEE LIMITED GUARANTEE, dated as of March 26, 2018 (this “Limited Guarantee”), by ShanghaiMed, Inc. (the “Guarantor”) in favor of iKang Healthcare Group, Inc., an exempted company with limited liability incorporated under the Laws of the Cayman Islands (the “Guaranteed Party”). 1. GUARANTEE. (a) To induce the Guarant |
|
| March 28, 2018 |
Exhibit 7.13 ShanghaiMed, Inc., Attn. Mr. Ligang Zhang Wickhams Cay I, Palm Grove House ROAD TOWN BRITISH VIRGIN ISLANDS Account no. 318.8688 Zurich, 22nd of March 2018 ADDENDUM to the Credit Agreement and the General Pledge and Assignment Agreement Dear Sirs We refer to the following documents agreed between Bank Julius Baer & Co. Ltd. (“the Bank”) and ShanghaiMed Inc., Road Town — British Virgin |
|
| March 28, 2018 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment SC 13D/A 1 a18-92431sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 6)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F |
|
| March 28, 2018 |
Exhibit 7.17 EXECUTION VERSION INTERIM INVESTORS AGREEMENT This Interim Investors Agreement (this “Agreement”) is made as of March 26, 2018 by and among Yunfeng Fund III, L.P. and Yunfeng Fund III Parallel Fund, L.P. (collectively “YFC”), each an exempted limited partnership established under the laws of the Cayman Islands, Taobao China Holding Limited, a company incorporated under the laws of Hon |
|
| March 26, 2018 |
iKang Enters into Definitive Merger Agreement for Going Private Transaction Exhibit 99.1 iKang Enters into Definitive Merger Agreement for Going Private Transaction BEIJING, March 26, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with IK Healthcar |
|
| March 26, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 1 |
|
| March 23, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 1 |
|
| March 23, 2018 |
iKang Announces Unaudited Financial Results for the Fiscal Third Quarter Ended December 31, 2017 EX-99.1 2 a18-89361ex99d1.htm EX-99.1 Exhibit 99.1 iKang Announces Unaudited Financial Results for the Fiscal Third Quarter Ended December 31, 2017 BEIJING, MARCH 22, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), major provider in China’s fast growing private preventive healthcare services market, today announced its unaudited financial results for |
|
| March 12, 2018 |
iKang Announces Receipt of Acquisition Proposal from Yunfeng Capital and Alibaba Exhibit 99.1 iKang Announces Receipt of Acquisition Proposal from Yunfeng Capital and Alibaba BEIJING, March 12, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced certain developments with respect to the previously disclosed potential going private t |
|
| March 12, 2018 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) 6-K 1 a18-806416k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2018 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Ch |
|
| February 12, 2018 |
KANG / iKang Healthcare Group, Inc. / Fosun International Ltd - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* IKANG HEALTHCARE GROUP, INC. (Name of Issuer) Class A Common Shares, par value US$0.01 per share (Title of Class of Securities) 45174L108 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box t |
|
| December 18, 2017 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) 6-K 1 a17-2853316k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2017 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Roa |
|
| December 18, 2017 |
iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2017 EX-99.1 2 a17-285331ex99d1.htm EX-99.1 Exhibit 99.1 iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2017 BEIJING, December 14, 2017 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced its unaudited financial res |
|
| December 4, 2017 |
Consent of King & Wood Mallesons Exhibit 15.2 December 4, 2017 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 People?s Republic of China Attention: The Board of Directors Dear Sirs, Re: iKang Healthcare Group, Inc. (the ?Company?) We, King & Wood Mallesons, consent to the reference to our firm under the captions of ?Item 3.D ? Risk Factors? in iKang Healthcare Group, Inc.?s annua |
|
| December 4, 2017 |
KANG / iKang Healthcare Group, Inc. 20-F/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 1) (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2017. OR o TRANSITION REPORT PURSUANT TO SEC |
|
| December 4, 2017 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Lee Ligang Zhang, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of iKang Healthcare Group, Inc. (the ?Company?); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material |
|
| December 4, 2017 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yang Chen, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of iKang Healthcare Group, Inc. (the ?Company?); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact n |
|
| December 1, 2017 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 4)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang |
|
| December 1, 2017 |
Exhibit 7.10 Dated 29 November 2017 Supplemental Deed With respect to the Equitable Mortgage Over Shares in iKang Healthcare Group, Inc. dated 25 August 2017 SHANGHAIMED, INC. and GOPHER GLOBAL CREDIT FUND II This Supplemental Deed is made on 29th day of November 2017. Between: (1) SHANGHAIMED, INC., a company incorporated and existing under the laws of the British Virgin Islands (registration num |
|
| December 1, 2017 |
SHARE PLEDGE CONTRACT CONTRACT NO.【AVICTC2017X1276-4】 Exhibit 7.11 SHARE PLEDGE CONTRACT CONTRACT NO.【AVICTC2017X1276-4】 This Share Pledge Contract (this “Contract”) is entered into in Nanchang, Jiangxi Province, China, as of November 19, 2017 by and among the following parties: (1) AVIC Trust Co., Ltd. (the “Pledgee”), a Sino-foreign joint venture incorporated and existing under the laws of the People’s Republic of China(“China” or “PRC”); (2) Shang |
|
| November 29, 2017 |
KANG / iKang Healthcare Group, Inc. 8-A12B/A 8-A12B/A 1 a17-2769918a12ba.htm 8-A12B/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A Amendment No. 2 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State of incorporation or organizatio |
|
| November 29, 2017 |
AMENDMENT NO. 2 TO RIGHTS AGREEMENT EX-4.1 2 a17-276981ex4d1.htm EX-4.1 Exhibit 4.1 AMENDMENT NO. 2 TO RIGHTS AGREEMENT EXECUTION VERSION AMENDMENT NO. 2 (this “Amendment”), dated as of November 29, 2017, to the Rights Agreement (the “Rights Agreement”), dated as of December 2, 2015, as amended by Amendment No.1 thereto dated November 28, 2016, by and between iKang Healthcare Group, Inc., a company incorporated under the laws of the |
|
| November 29, 2017 |
iKang Healthcare Group, Inc. Extends Shareholder Rights Plan Exhibit 99.1 iKang Healthcare Group, Inc. Extends Shareholder Rights Plan BEIJING, November 29, 2017 (GLOBE NEWSWIRE) ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), announced today that its Board of Directors has unanimously approved the extension of its Rights Agreement, presently scheduled to expire on December 2, 2017, for another year. As the Rights Agreement was des |
|
| November 29, 2017 |
KANG / iKang Healthcare Group, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2017 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijin |
|
| November 20, 2017 |
KANG / iKang Healthcare Group, Inc. ESP November 20, 2017 Mr. Terry French Mr. Charles Eastman Ms. Celeste M. Murphy Mr. Larry Spirgel Mr. Joshua Shainess Division of Corporation Finance Securities and Exchange Commission 100F Street, NE Mail Stop 7010 Washington, DC 20549 U.S.A. Re: iKang Healthcare Group, Inc. Form 20-F for the Fiscal Year Ended March 31, 2017 Filed August 15, 2017 File No. 001-36765 Dear Mr. French, Mr. Eastman, Ms. |
|
| November 14, 2017 |
KANG / iKang Healthcare Group, Inc. ESP November 14, 2017 Mr. Terry French Mr. Charles Eastman Ms. Celeste M. Murphy Mr. Larry Spirgel Mr. Joshua Shainess Division of Corporation Finance Securities and Exchange Commission 100F Street, NE Mail Stop 7010 Washington, DC 20549 U.S.A. Re: iKang Healthcare Group, Inc. Form 20-F for the Fiscal Year Ended March 31, 2017 Filed August 15, 2017 File No. 001-36765 Dear Mr. French, Mr. Eastman, Ms. |
|
| October 24, 2017 |
KANG / iKang Healthcare Group, Inc. ESP October 24, 2017 Mr. Terry French Mr. Charles Eastman Ms. Celeste M. Murphy Mr. Larry Spirgel Mr. Joshua Shainess Division of Corporation Finance Securities and Exchange Commission 100F Street, NE Mail Stop 7010 Washington, DC 20549 U.S.A. Re: iKang Healthcare Group, Inc. Form 20-F for the Fiscal Year Ended March 31, 2017 Filed August 15, 2017 File No. 001-36765 Dear Mr. French, Mr. Eastman, Ms. M |
|
| October 4, 2017 |
KANG / iKang Healthcare Group, Inc. ESP October 4, 2017 Mr. Terry French Mr. Charles Eastman Ms. Celeste M. Murphy Mr. Larry Spirgel Mr. Joshua Shainess Division of Corporation Finance Securities and Exchange Commission 100F Street, NE Mail Stop 7010 Washington, DC 20549 U.S.A. Re: iKang Healthcare Group, Inc. Form 20-F for the Fiscal Year Ended March 31, 2017 Filed August 15, 2017 File No. 001-36765 Dear Mr. French, Mr. Eastman, Ms. Mu |
|
| September 29, 2017 |
EX-99.1 2 v475968ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 or Section 16 of the Exchange Act or any r |
|
| September 29, 2017 |
KANG / iKang Healthcare Group, Inc. / Fosun International Ltd - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* IKANG HEALTHCARE GROUP, INC. (Name of Issuer) Class A Common Shares, par value US$0.01 per share (Title of Class of Securities) 45174L108 (CUSIP Number) September 20, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box t |
|
| September 15, 2017 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2017 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beiji |
|
| September 15, 2017 |
iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2017 EX-99.1 2 a17-221071ex99d1.htm EX-99.1 Exhibit 99.1 iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2017 BEIJING, September 14, 2017 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced its unaudited financial results |
|
| August 25, 2017 |
SHARE PLEDGE CONTRACT CONTRACT NO.AVICTC2016X0526-5 Exhibit 7.9 SHARE PLEDGE CONTRACT CONTRACT NO.AVICTC2016X0526-5 This Share Pledge Contract (this “Contract”) is entered into in Nanchang, Jiangxi Province, China as of September 9, 2016 by and among the following parties: (1) AVIC Trust Co., Ltd. (the “Pledgee”), a Sino-foreign joint venture incorporated and existing under the laws of the People’s Republic of China(“China” or “PRC”); (2) ShanghaiM |
|
| August 25, 2017 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 3)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Lee Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang |
|
| August 25, 2017 |
Exhibit 7.8 Execution Version Equitable Mortgage Over Shares in iKang Healthcare Group Inc. 25 August 2017 SHANGHAIMED, INC. (as Mortgagor) and GOPHER GLOBAL CREDIT FUND II (as Mortgagee) This Equitable Mortgage is made on 25 day of August 2017 Between: (1) SHANGHAIMED, INC., a company incorporated and existing under the laws of the British Virgin Islands (registration number: 572820) with its reg |
|
| August 25, 2017 |
Exhibit 7.7 Execution Version Dated 25 August 2017 Charge over Shares Relating to the share capital of iKang Healthcare Group, Inc. in relation to a US$19,000,000 Term Loan Facility between ShanghaiMed, Inc. as Chargor Gopher Global Credit Fund II as Chargee White & Case 9th Floor Central Tower 28 Queen’s Road Central Hong Kong, Hong Kong Table of Contents Page 1. Definitions and Interpretation 1 |
|
| August 15, 2017 |
Exhibit 4.7 AGREEMENT EXTENSION NOTICE To: iKang Healthcare Technology Group Co., Ltd. (Former Shanghai Guobin Medical Holding Co., Ltd., ?You?) Notice Date: April 26, 2017 We refer to the Exclusive Business Cooperation Agreement (the ?Cooperation Agreement?) dated April 27, 2007 and entered into by and among You and us therein. Subject to the Cooperation Agreement, the original validity period is |
|
| August 15, 2017 |
Exhibit 4.39 Equity Pledge Agreement This Equity Pledge Agreement (the ?Agreement?) is entered into on March 17, 2017 in Beijing by and among the following parties: Party A: Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. (the ?Pledgee?) Address: 75 Wanping South Road, Room 1801, Shanghai Party B: Hu Haiqing (the ?Pledgor?) ID number: 320102198102151619Address: 8 Chaoyangmen North Street |
|
| August 15, 2017 |
EX-4.44 10 a17-126511ex4d44.htm EX-4.44 Exhibit 4.44 Supplemental Agreement to the Loan Agreement This Supplemental Agreement to the Loan Agreement (hereinafter referred to as this “Supplemental Agreement”) is executed on January 17, 2017 by the Parties below in the People’s Republic of China (hereinafter referred to as “PRC”) in accordance with applicable PRC laws, regulations, and rules: Borrowe |
|
| August 15, 2017 |
Exhibit 4.46 Supplemental Agreement II to the Investment Agreement This Supplemental Agreement II to the Investment Agreement (hereinafter referred to as this “Supplemental Agreement II”) was executed by the following Parties on January 24, 2017 in the People’s Republic of China (hereinafter referred to as “PRC”) in accordance with applicable PRC laws, regulations, and rules: Investor: Shenzhen Xi |
|
| August 15, 2017 |
Consent of Conyers Dill & Pearman Exhibit 15.1 15 August, 2017 Matter No.:824853 Doc Ref: 103531237 The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) We refer to the annual report of the Company for the fiscal year ended 31 March, 2017 on Form 20-F filed pursuant to Section 13 or 15(D) |
|
| August 15, 2017 |
Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and 333-202544 on Form S-8, of our reports dated August 15, 2017, relating to the consolidated financial statements and financial statement schedule of iKang Healthcare Group, Inc., its subsidiaries, its variable interest entities(?VIEs?) |
|
| August 15, 2017 |
Exhibit 4.45 Supplemental Agreement II to the Loan Agreement This supplemental agreement to the loan agreement (hereinafter referred to as this “Supplemental Agreement”) is executed on July 10, 2017 by and between the Parties below in the People’s Republic of China (hereinafter referred to as “PRC”) in accordance with applicable PRC laws, regulations, and rules: Borrower: iKang Healthcare Technolo |
|
| August 15, 2017 |
Exhibit 15.2 August 15, 2017 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Attention: The Board of Directors Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) We, King & Wood Mallesons, consent to the reference to our firm under the captions of “Item 3.D — Risk Factors” and “Item 4.C — Organizational Structure |
|
| August 15, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2017. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| August 15, 2017 |
Exhibit 4.40 Equity Pledge Agreement This Equity Pledge Agreement (the “Agreement”) is entered into on March 17, 2017 in Beijing by and among the following parties: Party A: Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. (the “Pledgee”) Address: 75 Wanping South Road, Room 1801, Shanghai Party B: Tan Juan (the “Pledgor”) ID number: 440224198107072865Address: Diwang Mansion, No. 5002, Sh |
|
| August 15, 2017 |
EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Lee Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the ?Company?); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make |
|
| August 15, 2017 |
EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the ?Company?); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st |
|
| August 15, 2017 |
EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of iKang Healthcare Group, Inc. (the ?Company?) on Form 20-F for the year ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Lee Ligang Zhang, Chief Executive Officer of the Company, |
|
| August 15, 2017 |
Exhibit 4.37 Cooperation Agreement between iKang Healthcare Group, Inc. and iKang Health Technology Group Co., Ltd. and Ligang Capital Investment (Shenzhen) Co., Ltd. and Yuansheng Investment Management Co., Ltd. of Ningbo Meishan Bonded Port Area and China Industrial Asset Management Limited Contents 1 Definitions and Interpretations 2 2 Way of Cooperation 6 3 Establishment of Merger Fund 7 4 Inv |
|
| August 15, 2017 |
Exhibit 4.42 Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (?My Equity?) of Shanghai Yuanhua Information Technology Co., Ltd., hereby irrevocably authorize Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: Yuanhua Medical Co |
|
| August 15, 2017 |
EX-4.38 4 a17-126511ex4d38.htm EX-4.38 Exhibit 4.38 Exclusive Business Cooperation Agreement This Exclusive Business Cooperation Agreement (hereinafter the “Agreement”) is made by and between the following parties on March 17, 2017 in Shanghai, the People’s Republic of China (the “PRC”). Party A: Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. Address: 75 Wanping South Road, Room 1801, S |
|
| August 15, 2017 |
EX-4.43 9 a17-126511ex4d43.htm EX-4.43 Exhibit 4.43 Power of Attorney I, Tan Juan, with ID number of 440224198107072865, being a shareholder of 20% of the equity (“My Equity”) of Shanghai Yuanhua Information Technology Co., Ltd., hereby irrevocably authorize Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. to exercise the following rights with respect to My Equity within the term of this |
|
| August 15, 2017 |
EX-4.41 7 a17-126511ex4d41.htm EX-4.41 Exhibit 4.41 Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT (“this Agreement”) is made and entered into by and among the following parties on March 17, 2017 in Shanghai, the People’s Republic of China (the “PRC”). Party A: Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd., a wholly-owned Chinese subsidiary of a enterprise registered i |
|
| August 15, 2017 |
EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of iKang Healthcare Group, Inc. (the ?Company?) on Form 20-F for the year ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Yang Chen, Chief Financial Officer of the Company, certif |
|
| July 31, 2017 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2017 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 10 |
|
| July 31, 2017 |
iKang Group Announces Partnership To Establish IBM Watson Oncology Centers in China Exhibit 99.1 iKang Group Announces Partnership To Establish IBM Watson Oncology Centers in China Press Release BEIJING, July 28, 2017 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), a major provider in Chinas fast-growing private preventive healthcare services market, has officially announced its strategic partnership with BAHEAL Intelligent Technology t |
|
| July 31, 2017 |
iKang Healthcare Group NT 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 001-36403 CUSIP Number: 45174L108 (Check one): o Form 10-K x Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2017 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tran |
|
| July 20, 2017 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2017 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 10 |
|
| July 20, 2017 |
iKang to Form Healthcare Investment Funds with China Industrial Asset Management Limited EX-99.1 2 a17-181371ex99d1.htm EX-99.1 Exhibit 99.1 iKang to Form Healthcare Investment Funds with China Industrial Asset Management Limited BEIJING, July 19, 2017 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced that it will cooperate with China Industr |
|
| June 27, 2017 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2017 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 10 |
|
| June 27, 2017 |
Exhibit 99.1 iKang Group Launches New Strategic Initiatives, iKangCare+ and iKangPartners+ A comprehensive ?advisory? healthcare platform Press Release BEIJING, June 26, 2017 (GLOBE NEWSWIRE) ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq:KANG), a major provider in China?s fast-growing private preventive healthcare services market, has announced the launch of its key strategic i |
|
| June 23, 2017 |
Exhibit 99.1 iKang Announces Unaudited Financial Results for the Fiscal Fourth Quarter and the Fiscal Year 2016 ended March 31, 2017 BEIJING, June 22, 2017 (GLOBE NEWSWIRE) ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), a major provider in China?s fast growing private preventive healthcare services market, today announced its unaudited financial results for the fiscal fo |
|
| June 23, 2017 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2017 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 10 |
|
| March 17, 2017 |
iKang Announces Unaudited Financial Results for Fiscal Third Quarter Ended December 31, 2016 EX-99.1 2 a17-84501ex99d1.htm EX-99.1 Exhibit 99.1 iKang Announces Unaudited Financial Results for Fiscal Third Quarter Ended December 31, 2016 BEIJING, MARCH 16, 2017 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), major provider in China’s fast growing private preventive healthcare services market, today announced its unaudited financial results for the |
|
| March 17, 2017 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2017 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 1 |
|
| February 9, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 8, 2017 |
KANG / iKang Healthcare Group, Inc. / GIC Private Ltd - SC 13G/A Passive Investment SC 13G/A 1 s001535x1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* iKang Healthcare Group, Inc. (Name of Issuer) Class A common shares, par value US$0.01 per share, including in the form of American Depositary Shares (each representing 1/2 of a Class A common share) (Title of Cla |
|
| December 2, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2016 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijin |
|
| December 2, 2016 |
iKang Announces Unaudited Financial Results for the Second Quarter Ended September 30, 2016 Exhibit 99.1 iKang Announces Unaudited Financial Results for the Second Quarter Ended September 30, 2016 BEIJING, December 1, 2016 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), the largest provider in Chinas fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced |
|
| November 30, 2016 |
iKang Healthcare Group 8-A12B/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A Amendment No. 1 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State of incorporation or organization) (IRS Employer Identification No.) B-6F |
|
| November 30, 2016 |
AMENDMENT NO. 1 TO RIGHTS AGREEMENT Exhibit 4.1 AMENDMENT NO. 1 TO RIGHTS AGREEMENT EXECUTION VERSION AMENDMENT NO. 1 (this ?Amendment?), dated as of November 28, 2016, to the Rights Agreement (the ?Rights Agreement?), dated as of December 2, 2015, by and between iKang Healthcare Group, Inc., a company incorporated under the laws of the Cayman Islands (the ?Company?), and American Stock Transfer & Trust Company, L.L.C., a New York l |
|
| November 30, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2016. Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beiji |
|
| November 30, 2016 |
iKang Healthcare Group, Inc. Extends Shareholder Rights Plan Exhibit 99.1 iKang Healthcare Group, Inc. Extends Shareholder Rights Plan BEIJING, Nov. 28, 2016 (GLOBE NEWSWIRE) ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), announced today that its Board of Directors has unanimously approved the extension of its Rights Agreement, presently scheduled to expire on December 2, 2016, for another year. As the Rights Agreement was designe |
|
| September 1, 2016 |
iKang Announces Unaudited Financial Results for the First Quarter Ended June 30, 2016 Exhibit 99.1 iKang Announces Unaudited Financial Results for the First Quarter Ended June 30, 2016 BEIJING, August 31, 2016 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), the largest provider in Chinas fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced its un |
|
| September 1, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2016 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beiji |
|
| July 29, 2016 |
Exhibit 15.1 29 July, 2016 Matter No.:823187 Doc Ref: 102708437 +852 2842 9531 [email protected] [email protected] The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) We refer to the annual report of the Company for the fiscal year e |
|
| July 29, 2016 |
Exhibit 15.2 July 29, 2016 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Ladies and Gentlemen, We consent to the reference to our firm under the captions of “Item 3.D — Risk Factors” and “Item 4.C — Organizational Structure” in iKang Healthcare Group, Inc.’s annual report on Form 20-F for the year ended March 31, 2016, |
|
| July 29, 2016 |
Exhibit 4.39 Summary Translation of Investment Agreement Zhongjin Zhide Equity Investment Management Co., Ltd. (?Party A?) and iKang Healthcare Technology Group Co., Ltd. (?Party B?, or the ?Company?) entered into the Investment Agreement on December 11, 2015. Article 1. Terms of Loan and Conversion Subject to the satisfaction of the Company?s obligation under its certain representations and warra |
|
| July 29, 2016 |
Exhibit 4.36 Summary Translation of Capital Injection Agreement New China Life Insurance Co., Ltd. (?NCI?), iKang Guobin Healthcare Group Co., Ltd. (?iKang?), Shenzhen Top Spring Pu Chang Investment Management Co., Ltd. (?Top Spring Pu Chang?) and New China Life Insurance Health Investment Management Co., Ltd. (the ?Target Company?) entered into the Capital Injection Agreement (the ?Agreement?) on |
|
| July 29, 2016 |
EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the |
|
| July 29, 2016 |
EX-4.40 6 a16-116731ex4d40.htm EX-4.40 Exhibit 4.40 Summary Translation of Investment Agreement Tianjin Junlian Yunpeng Enterprise Management Consulting Partnership (Limited Partnership) (“Party A”), iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) and Beijing Junlian Xinhai Equity Investment Partnership (Limited Partnership) (“Party C”) entered into the Investment Agreeme |
|
| July 29, 2016 |
EX-4.37 3 a16-116731ex4d37.htm EX-4.37 Exhibit 4.37 Summary Translation of Loan Agreement iKang Healthcare Technology Group Co., Ltd. (the “Borrower”) and AVIC Trust Co., Ltd. (the “Lender”) entered into the Loan Agreement (the “Agreement”) on December 9, 2015. Article 1. The Loan Amount The amount of loan (“Loan”) hereunder is RMB500,000,000. Article 2. Usage of the Loan. 2.1 The Loan under this |
|
| July 29, 2016 |
Exhibit 4.38 Summary Translation of Investment Agreement Shenzhen Xingwang Great Health No.1 Investment Center (Limited Partnership) (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 7, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of |
|
| July 29, 2016 |
EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of iKang Healthcare Group, Inc. (the “Company”) on Form 20-F for the year ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yang Chen, Chief Financial Officer of the Company, certif |
|
| July 29, 2016 |
EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of iKang Healthcare Group, Inc. (the “Company”) on Form 20-F for the year ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ligang Zhang, Chief Executive Officer of the Company, cer |
|
| July 29, 2016 |
EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st |
|
| July 29, 2016 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and 333-202544 on Form S-8, of our reports dated July 29, 2016, relating to the consolidated financial statements and financial statement schedule of iKang Healthcare Group, Inc., its subsidiaries, variable interest entities (“VIEs”) and V |
|
| July 29, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F 20-F 1 a16-11673120f.htm 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2016. OR o TRANSITION REPORT PURSUAN |
|
| June 10, 2016 |
iKang Announces Further Update on Potential “Going Private” Transaction Exhibit 99.1 iKang Announces Further Update on Potential ?Going Private? Transaction BEIJING, June 9, 2016 (GLOBE NEWSWIRE) ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), China?s largest private preventive healthcare services provider, today announced a further update on the potential going private transaction proposed, respectively, by certain buyer groups, including (i |
|
| June 10, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2016 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 10 |
|
| June 7, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2016 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 10 |
|
| June 7, 2016 |
iKang Announces Receipt of Competing Non-Binding Going Private Proposal Exhibit 99.1 iKang Announces Receipt of Competing Non-Binding ?Going Private? Proposal BEIJING, June 06, 2016 (GLOBE NEWSWIRE) ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), China?s largest private preventive healthcare services provider, today announced that its board of directors (the ?Board?) received a preliminary non-binding proposal letter, dated June 6, 2016, from |
|
| June 7, 2016 |
EX-7.5 2 a16-129271ex7d5.htm EX-7.5 Exhibit 7.5 June 7, 2016 FV Investment Holdings 190 Elgin Avenue, George Town, Grand Cayman KY1-9005 Cayman Islands Attention: TANG Kui with a copy to: Suite 705-708 ICBC Tower 3 Garden Road Central, Hong Kong Attention: Wei Cai / Eric Chen / Brian Lee Alibaba Investment Limited c/o Alibaba Group Services Limited, 26/F, Tower One, Times Square, 1 Matheson Street |
|
| June 7, 2016 |
Exhibit 7.6 June 7, 2016 Special Committee of the Board of Directors iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Dear Members of the Special Committee, We refer to our preliminary non-binding proposal (the “Proposal”) to the board of directors of iKang Healthcare Group, Inc. (the “Company”), dated August 31, 2015, to |
|
| June 7, 2016 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment SC 13D/A 1 a16-129271sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 2)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Sh |
|
| May 25, 2016 |
iKang Sues Meinian Onehealth Healthcare Over IP Infringement Exhibit 99.1 iKang Sues Meinian Onehealth Healthcare Over IP Infringement BEIJING, May 24, 2016 iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), Chinas largest private preventive healthcare services provider, reported that, on April 28, 2016, the Company filed a complaint (the Copyright Claim) with the Shanghai Intellectual Property Court against Shanghai Mei Dong Softw |
|
| May 25, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) 6-K 1 a16-1220016k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2016 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Cha |
|
| May 20, 2016 |
Exhibit 99.1 iKang Announces Acquisition of Two Medical Centers in Beijing Continues to Enhance Its Presence in Tier 1 Cities BEIJING, May 20, 2016 ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), China?s largest private preventive healthcare services provider, today announced that it has completed the acquisition of 100% equity interest in Beijing Bohui Clinic Co. Ltd. (? |
|
| May 20, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2016 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100 |
|
| March 15, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2016 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 1 |
|
| March 15, 2016 |
iKang Announces Unaudited Financial Results for Fiscal Third Quarter Ended December 31, 2015 Exhibit 99.1 iKang Announces Unaudited Financial Results for Fiscal Third Quarter Ended December 31, 2015 BEIJING, March 14, 2016 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), the largest provider in Chinas fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced |
|
| February 12, 2016 |
KANG / iKang Healthcare Group, Inc. / GIC Private Ltd - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* iKang Healthcare Group, Inc. (Name of Issuer) Class A common shares, par value US$0.01 per share, including in the form of American Depositary Shares (each representing 1/2 of a Class A common share) (Title of Class of Securities) 45174L108 (CUSIP Number |
|
| February 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| February 2, 2016 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2016 Commission File Number: 001?36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B?6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijin |
|
| February 2, 2016 |
iKang Announces Equity Investment in New China Life Insurance Health Investment Management Co., Ltd. Exhibit 99.1 Press Release iKang Announces Equity Investment in New China Life Insurance Health Investment Management Co., Ltd. BEIJING, February 2, 2016 ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), China?s largest private preventive healthcare services provider, today announced that it has completed a strategic investment in New China Life Insurance Health Investment |
|
| January 5, 2016 |
AMENDED AND RESTATED CONSORTIUM AGREEMENT EX-7.4 2 a16-10411ex7d4.htm EX-7.4 Exhibit 7.4 Execution Version AMENDED AND RESTATED CONSORTIUM AGREEMENT THIS AMENDED AND RESTATED CONSORTIUM AGREEMENT is made as of January 5, 2016 (the “Agreement”), by and among Ligang Zhang (the “Chairman”), Time Intelligent Finance Limited, a British Virgin Islands company which is beneficially owned by the Chairman’s family trust (“TIFL”), ShanghaiMed, Inc. |
|
| January 5, 2016 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D/A Activist Investment SC 13D/A 1 a16-10411sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under Securities Exchange Act of 1934 (Amendment No. 1)* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Shi |
|
| December 23, 2015 |
Exhibit 99.1 Press Release iKang Announces Acquisition of Shaanxi INLUNG Health Management Expands its Network in Northwest China BEIJING, December 22, 2015 iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), Chinas largest private preventive healthcare services provider, today announced that it has acquired 70% equity interest of Xian iKang Health Management, which has 100 |
|
| December 23, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2015 Commission File Number: 00136403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing |
|
| December 7, 2015 |
KANG / iKang Healthcare Group, Inc. / JP Morgan Chase & Co Passive Investment SC 13G/A 1 iKangHealthcareGroup.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) ( AMENDMENT 1) iKang Healthcare Group, Inc. ( NAME OF ISSUER ) ADR (Title of Class of Securities) 45174L108 (CUSIP Number) November 30, |
|
| December 3, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 iKang Healthcare Group, Inc. (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State of incorporation or organization) (IRS Employer Identification No.) B-6F, Shimao Tower 92A |
|
| December 3, 2015 |
iKang Healthcare Group, Inc. ADOPTS RIGHTS AGREEMENT EX-99.1 Exhibit 99.1 PRESS RELEASE iKang Healthcare Group, Inc. ADOPTS RIGHTS AGREEMENT BEIJING, December 2, 2015? The Board of Directors of iKang Healthcare Group, Inc. (the ?Company?) today adopted a Rights Agreement and authorized the issuance of one Right for each outstanding Class A Common Share and Class C Common Share (the ?Rights Plan?). After careful consideration, the Board of Directors |
|
| December 3, 2015 |
iKang Healthcare Group FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2015. Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang Distri |
|
| December 3, 2015 |
EX-4.1 Exhibit 4.1 EXECUTION VERSION RIGHTS AGREEMENT dated as of December 2, 2015 between iKang Healthcare Group, Inc. and American Stock Transfer & Trust Company, L.L.C. as Rights Agent RIGHTS AGREEMENT Table of Contents Page ARTICLE I DEFINITIONS 1.1 Definitions 2 ARTICLE II THE RIGHTS 2.1 Summary of Rights 13 2.2 Legend 13 2.3 Exercise of Rights; Separation of Rights 15 2.4 Adjustments to Exer |
|
| November 30, 2015 |
iKang Announces Receipt of Competing Non-Binding “Going Private” Proposal Exhibit 99.1 iKang Announces Receipt of Competing Non-Binding ?Going Private? Proposal BEIJING, November 30, 2015 ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), China?s largest private preventive healthcare services provider, today announced that its board of directors (the ?Board?) received on November 29, 2015 a preliminary non-binding proposal letter, dated November 2 |
|
| November 30, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2015 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijin |
|
| November 30, 2015 |
2nd Fiscal Quarter Ended September 30, 2015 Exhibit 99.2 iKang Announces Unaudited Financial Results for Fiscal Second Quarter Ended September 30, 2015 BEIJING, November 30, 2015 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), the largest provider in Chinas fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today annou |
|
| November 12, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2015 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. (Exact name of registrant as specified in its charter) B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijin |
|
| November 12, 2015 |
iKang Special Committee Engages Financial Advisor and Legal Counsel EX-99.1 2 a15-228191ex99d1.htm EX-99.1 Exhibit 99.1 Press Release iKang Special Committee Engages Financial Advisor and Legal Counsel BEIJING, Nov. 10, 2015 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq:KANG), China’s largest private preventive healthcare services provider, today announced that the special committee (the “Special Committee”) of the Company’s bo |
|
| October 16, 2015 |
Announcement of Changes to the Board of Directors Exhibit 99.1 Press Release Announcement of Changes to the Board of Directors BEIJING, Oct 15, 2015 Board of Directors of iKang Healthcare Group, Inc. (iKang or the Company) (NASDAQ: KANG), announces the resignation of Mr. David Ying Zhang as an independent director and a member of the Compensation Committee of the Board. The Chairman and the Board would like to convey their sincere gratitude |
|
| October 16, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2015 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People?s Republic of China (Address of principa |
|
| September 10, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2015 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People?s Republic of China (Address of princi |
|
| September 10, 2015 |
EX-99.1 2 a15-192301ex99d1.htm EX-99.1 Exhibit 99.1 iKang Announces Formation of a Special Committee to Evaluate Preliminary Non-Binding “Going Private” Proposal BEIJING, September 10, 2015 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), China’s largest private preventive healthcare services provider, today announced that in response to the preliminary non-binding proposa |
|
| September 9, 2015 |
FORM OF JOINT FILING AGREEMENT EX-7.1 2 a15-191631ex7d1.htm EX-7.1 Exhibit 7.1 FORM OF JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendme |
|
| September 9, 2015 |
EX-7.3 4 a15-191631ex7d3.htm EX-7.3 Exhibit 7.3 August 31, 2015 The Board of Directors iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Mr. Ligang Zhang (“Mr. Zhang”), Founder, Chairman of the Board of Directors (the “Board”), and Chief Executive Officer of iKang Healthcare Group, Inc. (the “Company”) and certain of his a |
|
| September 9, 2015 |
KANG / iKang Healthcare Group, Inc. / Zhang Ligang - SC 13D Activist Investment SC 13D 1 a15-191631sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under Securities Exchange Act of 1934 (Amendment No. )* iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Ligang Zhang c/o iKang Healthcare Group, Inc. B-6F Shimao Tow |
|
| September 9, 2015 |
Exhibit 7.2 CONSORTIUM AGREEMENT THIS CONSORTIUM AGREEMENT is made as of August 31, 2015 (the “Agreement”), by and among Ligang Zhang (the “Chairman”), Time Intelligent Finance Limited, a British Virgin Islands company which is beneficially owned by the Chairman’s family trust (“TIFL”), ShanghaiMed, Inc., a British Virgin Islands company wholly owned and controlled by the Chairman (“SMI”, and toge |
|
| August 31, 2015 |
Exhibit 99.1 iKang Announces Receipt of Preliminary Non-Binding ?Going Private? Proposal BEIJING, August 31, 2015 ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), China?s largest private preventive healthcare services provider, today announced that its board of directors (the ?Board?) has received a non-binding proposal letter, dated August 31, 2015, from Mr. Ligang Zhang |
|
| August 31, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2015 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People?s Republic of China (Address of principal |
|
| August 25, 2015 |
1st Fiscal Quarter Ended June 30, 2015 EX-99.1 2 a15-184541ex99d1.htm EX-99.1 Exhibit 99.1 iKang Announces Unaudited Financial Results for Fiscal First Quarter Ended June 30, 2015 BEIJING, August 24, 2015 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), the largest provider in China’s fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in |
|
| August 25, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2015 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People?s Republic of China (Address of principal |
|
| August 19, 2015 |
Exhibit 99.1 Press Release iKang Announces Acquisition of Three Ciming Medical Centers in Shandong Continues to Bolster Its Presence in East China BEIJING, August 18, 2015 ? iKang Healthcare Group, Inc. (?iKang? or the ?Company?) (Nasdaq: KANG), China?s largest private preventive healthcare services provider, today announced that it has formed a joint venture (?Joint Venture?) with former sharehol |
|
| August 19, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2015 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People?s Republic of China (Address of principal |
|
| July 27, 2015 |
EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of iKang Healthcare Group, Inc. (the “Company”) on Form 20-F for the year ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yang Chen, Chief Financial Officer of the Company, certif |
|
| July 27, 2015 |
Exhibit 15.2 July 27, 2015 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Ladies and Gentlemen, We consent to the reference to our firm under the captions of “Item 3.D — Risk Factors” and “Item 4.C — Organizational Structure” in iKang Healthcare Group, Inc.’s annual report on Form 20-F for the year ended March 31, 2015, |
|
| July 27, 2015 |
EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the |
|
| July 27, 2015 |
Exhibit 15.1 27 July, 2015 Matter No.:821355 Doc Ref: 101950513 +852 2842 9531 [email protected] [email protected] The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 People’s Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the “Company”) We refer to the annual report of the Company for the fiscal year e |
|
| July 27, 2015 |
Exhibit 4.33 Equity Transfer Agreement This Equity Transfer Agreement (hereinafter referred to as “this Agreement”) is executed as of February 10th 2015 by and between the following parties in Beijing, China: Hunan Fengxun Digital Technology Co., Ltd. (hereinafter referred to as the “Transferor”) Domicile: Room 206 Headquarter Building, Changsha Zhongdian Software Park, No.39 Jianshan Road, Changs |
|
| July 27, 2015 |
EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st |
|
| July 27, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2015. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH |
|
| July 27, 2015 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and No. 333-202544 on Form S-8, of our reports dated July 27, 2015, relating to the consolidated financial statements and financial statement schedule of iKang Healthcare Group, Inc., its subsidiaries, its variable interest entities (“VIEs |
|
| July 27, 2015 |
EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of iKang Healthcare Group, Inc. (the “Company”) on Form 20-F for the year ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ligang Zhang, Chief Executive Officer of the Company, cer |
|
| June 29, 2015 |
iKang Announces Acquisition of Two Medical Centers in Yantai Increases Reach of Nationwide Network Exhibit 99.1 Press Release iKang Announces Acquisition of Two Medical Centers in Yantai Increases Reach of Nationwide Network BEIJING, June 24, 2015 iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), Chinas largest private preventive healthcare services provider, has acquired 100% equity interest in Yantai Hongkang Tijian Co. Ltd. and Yantai Hongkang Jiankang Tijian Co. Ltd |
|
| June 29, 2015 |
iKang Healthcare Group 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2015 Commission File Number: 001-36403 IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People?s Republic of China (Address of principal e |
